Neurode, an innovative Australian start-up, is reshaping the way attention-deficit/hyperactivity disorder (ADHD) is treated. Departing from the traditional reliance on medication, the company has developed a non-invasive headband that delivers light electrical stimulation to the brain.
Founded by neuroscientist Nathalie Gouailhardou, who was diagnosed with ADHD at just five years old, and engineer Damian Sofrevski, Neurode has already generated significant attention. The company raised AUD 5.3 million (approximately US$3.7 million) to bring its device to market and boasts a waiting list of thousands eager to test it.
Current ADHD treatments often involve a laborious journey of trial and error with medications, which can be both expensive and time-consuming. Gouailhardou notes that ADHD treatment is complex, with some patients needing to try various medications before finding the right dosage. “As my doctor says,” she explains, “the treatment in which the pros outweigh the cons.”
These medications primarily stimulants like dexamphetamine and methylphenidate can have their own challenges, including restricted access and numerous side effects. Additionally, non-stimulant alternatives remain limited. For those who do find effective medication, it can indeed be life-changing. However, the need for alternative solutions is clear.
Neurode’s device uses light electrical stimulation to target the brain’s prefrontal cortex (PFC), the area responsible for executive function and focus. Users report either no sensation or mild tingling while wearing the headband for just 20 minutes a day. Unlike medications, which can cause side effects like anxiety, sleep disturbances, and increased heart rate, this approach is non-invasive and designed to help manage key symptoms such as focus, memory, and impulse control.
The device is paired with a brain-monitoring app that allows users to track changes in their brain activity over time. “We let you view your brain activity and understand how that relates to your ADHD—an MRI in your pocket,” the founders explained. This data-driven feedback aims to help users better understand their condition and how the stimulation is affecting their executive function.
Gouailhardou’s struggle with medications inspired her to create this technology, aiming to offer those with ADHD a better way to manage symptoms without relying on pharmaceuticals. The Neurode headband also includes an AI assistant named Rae, which helps users stay organized by creating personalized to-do lists and reducing feelings of overwhelm.
While the device is still in its development phase, further research is needed to compare its effectiveness against traditional treatments. The company hopes to expand its technology to address other conditions such as cognitive decline and depression.
For now, interested users in the US can sign up to be part of the beta-testing phase of the headband.
Source: Neurode